Anbio Biotechnology (NASDAQ:NNNN) Announces Quarterly Earnings Results

Anbio Biotechnology (NASDAQ:NNNN) released its quarterly earnings results on Tuesday. The company reported $0.03 EPS for the quarter, FiscalAI reports.

Anbio Biotechnology Price Performance

Shares of NASDAQ NNNN traded up $1.22 during mid-day trading on Tuesday, hitting $27.37. 25,304 shares of the company were exchanged, compared to its average volume of 55,097. The business’s 50 day moving average is $23.88. Anbio Biotechnology has a 1-year low of $5.89 and a 1-year high of $55.65.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, April 1st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.